Collegium Pharmaceutical Inc (COLL)
Activity ratios
Short-term
Turnover ratios
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inventory turnover | 7.15 | 5.93 | 7.88 | 7.25 | 7.44 | 7.77 | 10.65 | 8.71 | 5.47 | 3.14 | 2.16 | 1.61 | 7.26 | 7.46 | 6.52 | 8.05 | 8.34 | 8.59 | 8.67 | 11.40 |
| Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Payables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Working capital turnover | 1.51 | — | 11.89 | 6.11 | 7.11 | 7.54 | 5.25 | 6.13 | 3.10 | — | — | — | 3.25 | 3.46 | 3.56 | 4.86 | 3.58 | 15.64 | — | — |
The Inventory Turnover ratio for Collegium Pharmaceutical Inc has shown fluctuation over the years, indicating changes in the efficiency of managing inventory levels. The ratio decreased from 11.40 on March 31, 2020, to 1.61 on March 31, 2022, suggesting a decline in the frequency with which the company turned over its inventory. There was a gradual improvement in the ratio from March 31, 2022, reaching 7.15 by December 31, 2024, which could signify better inventory management.
The Receivables Turnover and Payables Turnover ratios are not available for analysis, as the data is not provided.
The Working Capital Turnover ratio reflects how effectively the company is utilizing its working capital to generate sales. Collegium Pharmaceutical Inc's efficiency in this aspect varied significantly over the years. For instance, the ratio was 15.64 on September 30, 2020, dropped to 3.25 by December 31, 2021, and then increased to 11.89 on June 30, 2024. These fluctuations indicate changes in the company's ability to generate revenue in relation to its working capital.
In conclusion, Collegium Pharmaceutical Inc should focus on improving its inventory management practices to enhance efficiency, and continue monitoring and optimizing its working capital turnover to drive sales growth.
Average number of days
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Days of inventory on hand (DOH) | days | 51.08 | 61.54 | 46.34 | 50.36 | 49.05 | 46.95 | 34.28 | 41.90 | 66.71 | 116.07 | 169.10 | 226.10 | 50.29 | 48.91 | 55.97 | 45.33 | 43.78 | 42.49 | 42.12 | 32.01 |
| Days of sales outstanding (DSO) | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Number of days of payables | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
The Days of Inventory on Hand (DOH) ratio for Collegium Pharmaceutical Inc has fluctuated over the past few years. It increased from 32.01 days as of March 31, 2020, to a peak of 226.10 days as of March 31, 2022, before steadily decreasing to 51.08 days as of December 31, 2024. This indicates that the company had a significant amount of inventory on hand compared to its sales, possibly signaling inefficiencies in managing inventory levels and potential risks of obsolescence.
The Days of Sales Outstanding (DSO) and Number of Days of Payables ratios were not available for analysis, as the data was not provided. DSO measures the average number of days it takes for the company to collect revenue after a sale, while the Number of Days of Payables ratio indicates the average number of days it takes for the company to pay its suppliers.
In conclusion, the trend in the Days of Inventory on Hand ratio for Collegium Pharmaceutical Inc suggests the need for closer monitoring and optimization of inventory management practices to improve operational efficiency and potentially reduce holding costs.
Long-term
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fixed asset turnover | — | — | — | — | — | — | 29.76 | 27.81 | 23.77 | 18.32 | 11.52 | 13.51 | 14.20 | 16.60 | 11.83 | 16.26 | 16.33 | 17.35 | 12.65 | 13.57 |
| Total asset turnover | 0.38 | 0.37 | 0.55 | 0.51 | 0.50 | 0.46 | 0.44 | 0.43 | 0.40 | 0.30 | 0.25 | 0.22 | 0.40 | 0.44 | 0.46 | 0.50 | 0.48 | 0.48 | 0.47 | 0.47 |
Based on the provided data, Collegium Pharmaceutical Inc's long-term activity ratios show some interesting trends over the years.
1. Fixed Asset Turnover:
- The fixed asset turnover ratio measures how efficiently a company is utilizing its fixed assets to generate revenue. Collegium Pharmaceutical Inc's fixed asset turnover has fluctuated over the years, ranging from a low of 11.52 to a high of 29.76.
- There was a general increasing trend in fixed asset turnover from March 31, 2020, to March 31, 2023, indicating improved efficiency in utilizing fixed assets to generate sales.
- However, the fixed asset turnover ratio declined significantly from March 31, 2023, to June 30, 2023, before reaching its highest point at 29.76 on June 30, 2023. This sharp increase suggests a significant improvement in efficiency before the data becomes unavailable for the remaining periods.
2. Total Asset Turnover:
- The total asset turnover ratio measures how efficiently a company is using its total assets to generate revenue. Collegium Pharmaceutical Inc's total asset turnover ratio fluctuated over the years, with a range from 0.22 to 0.55.
- The total asset turnover ratio decreased significantly from March 31, 2020, to June 30, 2020, before showing slight fluctuations up to December 31, 2021.
- There was a significant decrease in the total asset turnover from March 31, 2022, to June 30, 2022, reaching its lowest point of 0.22, indicating a potential decline in asset efficiency.
- However, the total asset turnover ratio showed an increasing trend from December 31, 2022, to June 30, 2024, suggesting improved efficiency in asset utilization over the latter part of the period.
In conclusion, the analysis of Collegium Pharmaceutical Inc's long-term activity ratios shows fluctuating trends in both fixed asset turnover and total asset turnover. While there were periods of both improvement and decline in efficiency, a detailed assessment of the company's operations and asset management practices would be needed to fully understand the reasons behind these fluctuations.